Genprex, Inc. financial data

Symbol
GNPX on Nasdaq
Location
1601 Trinity Street, Bldg. B, Suite 3.322, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -56%
Return On Equity -809 % -154%
Return On Assets -387 % -72%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.5M shares +1193%
Common Stock, Shares, Outstanding 33.1M shares +1197%
Entity Public Float 4.8M USD -90.1%
Common Stock, Value, Issued 33.1K USD +1197%
Weighted Average Number of Shares Outstanding, Basic 27.6M shares +1176%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.6M USD -19.9%
General and Administrative Expense 6.67M USD -48.6%
Costs and Expenses 17.3M USD -34.1%
Operating Income (Loss) -17.3M USD +34.1%
Net Income (Loss) Attributable to Parent -17.3M USD +33.9%
Earnings Per Share, Basic 1 USD/shares +94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.35M USD -45.2%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 2.06M USD -53.2%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Other Assets, Noncurrent 1.77M USD -19.8%
Assets 3.83M USD -42%
Liabilities, Current 2.44M USD +7.84%
Retained Earnings (Accumulated Deficit) -163M USD -11.8%
Stockholders' Equity Attributable to Parent 1.39M USD -68%
Liabilities and Equity 3.83M USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.16M USD +21.5%
Net Cash Provided by (Used in) Financing Activities 6.03M USD -11.3%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 33.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.87M USD +26.2%
Deferred Tax Assets, Valuation Allowance 27.6M USD +17.9%
Deferred Tax Assets, Gross 28.2M USD +17.1%
Depreciation 1.74K USD -85.7%
Deferred Tax Assets, Operating Loss Carryforwards 20.2M USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 81M USD -49.2%
Additional Paid in Capital 165M USD +9.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 459K USD -77.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%